Bacterial toxins: Potential weapons against HIV infection

被引:15
作者
Alfano, M
Rizzi, C
Corti, D
Adduce, L
Poli, G
机构
[1] Ist Sci San Raffaele, Dept Immunol & Infect Dis, AIDS Immunopathogenesis Unit, I-20132 Milan, Italy
[2] Univ Vita Salute San Raffaele, Sch Med, San Raffaele Sci Inst, I-20132 Milan, Italy
关键词
D O I
10.2174/1381612054546725
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Natural toxins are the product of a long-term evolution, and have captured crucial events in the most essential and vital processes of living organisms. They can attack components of the protein synthesis machinery (as in the case of Diphteria and Shiga toxins, and Ribosome inactivating proteins), actin polymerization (Clostridium botulinum type C, C2, toxins and Enterotoxin A), signal transduction pathways (Cholera toxin, Heat-labile enterotoxins, Pertussis and Adenylate cyclase toxins), intracellular trafficking of vesicules (for Tetanus and Botulinum neurotoxin type C) as well as immune and/or inflammatory responses (Pyrogenic exotoxins, Cholera and Pertussis toxins). Of interest is the fact that several bacterial and vegetal toxins can either kill selectively cells infected with the human immunodeficiency virus (HIV) or exert inhibitory effects on its life cycle. In particular both pertussis toxin (PTX) and its nontoxic B-oligomeric component (PTX-B) can block the infectious process in vitro at multiple levels, by preventing the entry of CCR5-dependent (R5) HIV strains and by inhibiting both R5 and CXCR4-dependent HIVs at post-entry level(s). In addition, some toxins possess immunostimulating properties that have been exploited in terms of adjuvancy and induction of specific cytotoxic T lymphocytes responses to different vaccine preparations, including some experimental vaccine against HIV infection. Thus, toxins may represent a relatively unexplored exhibition of powerful biological agents that could either prevent infection or attack HIV-infected cells.
引用
收藏
页码:2909 / 2926
页数:18
相关论文
共 305 条
[1]
Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins [J].
Abu, DI ;
Jones-Trower, A ;
Woron, AM ;
Stellrecht, K ;
Broder, CC ;
Metzger, DW .
JOURNAL OF VIROLOGY, 2003, 77 (10) :5589-5597
[2]
The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages [J].
Alfano, M ;
Pushkarsky, T ;
Poli, G ;
Bukrinsky, M .
JOURNAL OF VIROLOGY, 2000, 74 (18) :8767-8770
[3]
Alfano M., 2002, Current Molecular Medicine (Hilversum), V2, P677, DOI 10.2174/1566524023361925
[4]
The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells [J].
Alfano, M ;
Vallanti, G ;
Biswas, P ;
Bovolenta, C ;
Vicenzi, E ;
Mantelli, B ;
Pushkarsky, T ;
Rappuoli, R ;
Lazzarin, A ;
Bukrinsky, M ;
Poli, G .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :1863-1870
[5]
The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains [J].
Alfano, M ;
Schmidtmayerova, H ;
Amella, CA ;
Pushkarsky, T ;
Bukrinsky, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :597-605
[6]
PURIFICATION AND CHARACTERIZATION OF A SHIGA-TOXIN-A SUBUNIT-CD4 FUSION PROTEIN CYTOTOXIC TO HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS [J].
ALJAUFY, AY ;
KING, SR ;
JACKSON, MP .
INFECTION AND IMMUNITY, 1995, 63 (08) :3073-3078
[7]
CYTOTOXICITY OF A SHIGA TOXIN-A SUBUNIT-CD4 FUSION PROTEIN TO HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS [J].
ALJAUFY, AY ;
HADDAD, JE ;
KING, SR ;
MCPHEE, RA ;
JACKSON, MP .
INFECTION AND IMMUNITY, 1994, 62 (03) :956-960
[8]
THE 70-KILODALTON PERTUSSIS TOXIN-BINDING PROTEIN IN JURKAT CELLS [J].
ARMSTRONG, GD ;
CLARK, CG ;
HEERZE, LD .
INFECTION AND IMMUNITY, 1994, 62 (06) :2236-2243
[9]
Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines [J].
Arrington, J ;
Braun, RP ;
Dong, LC ;
Fuller, DH ;
Macklin, MD ;
Umlauf, SW ;
Wagner, SJ ;
Wu, MS ;
Payne, LG ;
Haynes, JR .
JOURNAL OF VIROLOGY, 2002, 76 (09) :4536-4546
[10]
ASHORN P, 1990, ANN NY ACAD SCI, V616, P149